What is JK Pharmachem share price return in the past 10 years?

Data is not available for this company

JK Pharmachem Ltd - Stock Valuation and Financial Performance

Name: JK Pharmachem
Brand: JK Pharmachem

BSE: 500218 | NSE: JKPHARMA | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on JK Pharmachem

Based on:

Data

M-Cap below 100cr DeciZen not available

JK Pharmachem stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

11.2 Cr.

52-wk low:

52-wk high:

Is an attractive stock to invest in?

1. Is a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that JK Pharmachem Ltd is a average quality company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of JK Pharmachem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Sep'96	Sep'97	Sep'98	Sep'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05	TTM
ROCE % ⓘ	0%	0%	-0.5%	-4.2%	-7.9%	-4.4%	7.9%	-1.2%	-19.6%	-5.6%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	71.8	68.5	72.9	70.3	95.3	78.4	38.4	5.2	0
Sales YoY Gr.	-	NA	NA	-4.5%	6.3%	-3.5%	35.5%	-17.8%	-51%	-86.4%	-
Adj EPS ⓘ	0	0	-3.6	-4.8	-3.7	-2.3	0.7	-1.1	-4.9	-1.7	-1.3
YoY Gr.	-	NA	NA	NA	NA	NA	NA	-271.2%	NA	NA	-
BVPS (₹) ⓘ	0	0	9.3	4.6	2.9	0.8	2.7	1.9	-4	-6	-6.5
Adj Net Profit ⓘ	0	0	-14.8	-19.9	-23	-14.2	4.2	-7.1	-30.5	-10.7	-8
Cash Flow from Ops. ⓘ	0	0	8.6	8	6.4	8.2	13.1	8.2	2.4	3.5	-
Debt/CF from Ops. ⓘ	0	0	16	17.4	16.3	13.1	7.9	12.3	44.1	31.4	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-41%	-62%	-86.4%
Adj EPS ⓘ	NA	NA	-237.4%	NA
BVPSⓘ	NA	-215.8%	-230.6%	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Sep'98	Sep'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05	TTM
Return on Equity % ⓘ	-33.5	-50.9	-52.8	-31	9.5	-15.2	-121.5	-7629.2	21
Op. Profit Mgn % ⓘ	16.6	9.7	0.4	7.5	21.9	11.5	-37.2	-81.6	-2583.3
Net Profit Mgn % ⓘ	-20.6	-29	-31.6	-20.2	4.4	-9.1	-79.4	-204.4	-13685.1
Debt to Equity ⓘ	3.6	4.9	2.1	3	2.1	2.3	17.7	-18.2	-
Working Cap Days ⓘ	0	136	121	113	90	123	196	684	0
Cash Conv. Cycle ⓘ	0	52	45	29	29	73	123	-121	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - JK Pharmachem Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-1.3	-
TTM Sales (₹ Cr.)	0.1	-
BVPS (₹.) ⓘ	-6.5	-
Reserves (₹ Cr.) ⓘ	-103	-
P/BV ⓘ	-0.28	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	1.10 / 26.00
Market Cap (₹ Cr.)	11.2
Equity (₹ Cr.)	62.7
Face Value (₹)	10
Industry PE ⓘ	48.8

Management X-Ray of JK Pharmachem:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of JK Pharmachem

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of JK Pharmachem

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Sep'98	Sep'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Sales	71.78	68.53	72.87	70.34	95.33	78.35	38.37	5.23
Operating Expenses ⓘ	59.92	61.90	72.62	65.17	74.47	69.37	52.72	9.81
Manufacturing Costs	20.15	21.56	30.79	26.47	28.05	31.38	23.74	1
Material Costs	29.83	30.98	33.35	30.99	35.88	30.69	20.49	5.38
Employee Cost	2.83	3.06	3.48	3.36	3.90	3.88	3.83	1.37
Other Costs ⓘ	7.10	6.30	5	4.35	6.64	3.42	4.66	2.07
Operating Profit ⓘ	11.86	6.63	0.24	5.17	20.85	8.98	-14.35	-4.59
Operating Profit Margin (%)	16.5%	9.7%	0.3%	7.3%	21.9%	11.5%	-37.4%	-87.7%
Other Income ⓘ	2.64	1.01	0.76	0.26	0.76	0.77	0.35	0.45
Interest ⓘ	19.70	17.83	14.26	10.71	10.75	7.50	7.49	6.58
Depreciation ⓘ	9.59	9.69	9.80	9.01	9.88	9.75	9.96	0.19
Exceptional Items ⓘ	0	0	0	0	3.75	1.34	3.15	0
Profit Before Tax ⓘ	-14.79	-19.89	-23.06	-14.28	4.73	-6.17	-28.30	-10.91
Tax ⓘ	0	0	0	0	-2.05	0	0	0.01
Profit After Tax	-14.79	-19.89	-23.06	-14.28	6.78	-6.17	-28.30	-10.91
PAT Margin (%)	-20.6%	-29.0%	-31.6%	-20.3%	7.1%	-7.9%	-73.8%	-208.0%
Adjusted EPS (₹)	-3.6	-4.8	-3.7	-2.3	1.1	-1.0	-4.5	-1.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Sep'98	Sep'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Equity and Liabilities
Shareholders Fund	44.16	33.94	53.18	38.57	49.40	43.76	6.38	-6.10
Share Capital ⓘ	41.37	51.37	94	94	94	94	94	94
Reserves ⓘ	2.79	-17.43	-40.82	-55.44	-44.60	-50.24	-87.62	-100.10
Minority Interest	0	0	0	0	0	0	0	0
Debt	138.16	139.82	104.33	106.83	102.84	100.08	106.73	111.08
Long Term Debt	138.16	139.82	104.33	106.83	102.84	100.08	106.73	111.08
Short Term Debt	0	0	0	0	0	0	0	0
Trade Payables	11.60	11.80	13.31	12.24	7.61	7.05	6.04	3.73
Others Liabilities ⓘ	1.38	1.97	3.11	4.43	-3.01	-2.64	5.31	3.84
Total Liabilities ⓘ	195.30	187.53	173.93	162.06	156.83	148.25	124.45	112.55
Fixed Assets
Gross Block	185.71	188.29	188.87	189.51	190.51	191.66	192.49	191.80
Accumulated Depreciation	28.25	37.86	47.54	56.44	66.17	75.77	85.65	85.64
Net Fixed Assetsⓘ	157.46	150.42	141.33	133.07	124.34	115.89	106.84	106.17
CWIP ⓘ	0.27	0.68	1.28	1.48	0.08	0.03	0	0
Investmentsⓘ	0.04	0.11	0.11	0.11	0.11	0.11	0.11	0.11
Inventories	11.32	8.33	9.16	8	7.19	10.43	9.69	3.15
Trade Receivables	14.67	17.06	13.18	12.07	18.45	17	2.66	0.02
Cash Equivalents	2	1.72	0.70	0.82	1	0.22	0.39	0.09
Others Assetsⓘ	9.54	9.20	8.17	6.50	5.67	4.56	4.76	3.01
Total Assets ⓘ	195.30	187.53	173.93	162.06	156.83	148.25	124.45	112.55

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Sep'98	Sep'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Cash Flow From Operating Activity ⓘ	8.61	8.03	6.41	8.17	13.07	8.16	2.42	3.54
PBT ⓘ	-14.78	-19.88	-23.06	-14.28	0.98	-7.51	-31.45	-10.91
Adjustment ⓘ	29.05	28.38	25.03	20.71	21.59	17.41	17.58	7.04
Changes in Working Capital ⓘ	-4.28	0.21	4.7	1.73	-9.49	-1.75	16.29	7.4
Tax Paid ⓘ	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	-2.43	-3.08	-1.33	-1.04	0.24	-1.41	-0.82	0.17
Capex	-2.43	-3	-1.33	-1.04	0.24	-1.41	-0.82	0.17
Net Investments	0	-0.08	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	-5.73	-5.24	-6.09	-7.01	-13.14	-7.52	-1.43	-4.01
Net Proceeds from Shares ⓘ	0	10	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	21.42	0	0	0	0	0	0
Interest Paid ⓘ	-6.48	-34.64	-4.45	-6.50	-5.80	-1.92	-1.54	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0
Others ⓘ	0.75	-2.02	-1.64	-0.50	-7.34	-5.60	0.11	-4.01
Net Cash Flow ⓘ	0.45	-0.28	-1.02	0.12	0.17	-0.77	0.17	-0.30

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Sep'98	Sep'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Ratios
ROE (%)	-38.62	-69.62	-125.23	-126.04	63.13	-43.29	0	N/A
ROCE (%)	2.78	-1.19	-5.46	-2.41	10.54	0.91	-16.27	N/A
Asset Turnover Ratio	0.43	0.42	0.47	0.49	0.69	0.59	0.33	0.05
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	1.93	N/A	N/A	N/A
Working Capital Days
Receivable Days	64	73	65	56	51	71	80	80
Inventory Days	49	45	38	38	25	35	82	382
Payable Days	142	138	137	150	101	87	117	332

JK Pharmachem Ltd Stock News

JK Pharmachem Ltd FAQs

What is the share price of JK Pharmachem?

Company share prices are keep on changing according to the market conditions. The closing price of JK Pharmachem on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of JK Pharmachem?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of JK Pharmachem stood at ₹11.22.

What is the P/E ratio of JK Pharmachem?

The latest P/E ratio of JK Pharmachem as of 01-Jan-1970 05:30 is 0.00.

What is the P/B ratio of JK Pharmachem?

The latest P/B ratio of JK Pharmachem as of 01-Jan-1970 05:30 is -0.28.

What is the 52-week high and low of JK Pharmachem?

The 52-week high of JK Pharmachem is ₹0.00 and the 52-week low is ₹0.00.

What is the TTM revenue of JK Pharmachem?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of JK Pharmachem is ₹0.06 ( Cr.) .

About JK Pharmachem Ltd

JK Pharmachem was incorporated on March 16, 1990. The company produces penicillin-G at its Cuddalore plant in Tamil Nadu with an installed capacity of 1,250 MMU.

The company has its own research and development facility for bio-technology research. With its net worth fully eroded, the company is under receivership now. It has been suspended from BSE on account of non compliance with listing agreement clauses.

The registered office of the company is located at A-7 SIPCOT Industrial Complex, South Arcot, Vallalar district, Cuddalore, Tamil Nadu-607005.

Business area of the company

The company is engaged in the manufacture of drugs and pharmaceuticals.